MedWatch

Top picks in English

Denmark to participate in international Horizon scanning program

The Danish government allocates DKK 54 million (USD 8.46 million) to ensure Danish participation in a new international program to obtain information about future drugs. The pharmaceutical procurement service Amgros and the Danish Medicines Agency welcome the initiative.

Danish cancer vaccine patented in the US

Adaptvac, a joint venture between a Copenhagen University spinout and Danish Expres2ion, has taken out a patent in the US on a new breast cancer vaccine. "An important milestone," says the chairman.

Novo's innovation hunter brings back abandoned project

A new collaboration to identify small molecules against diabetes and secondary complications provides the framework for Novo Nordisk's future bet on oral drugs based on small molecules - a research field the company originally gave up in 2007.

Leo challenges Novartis with tablet agreement

Leo Pharma has signed a global licensing agreement for a new candidate. It will be the company's first tablet therapy against atopic dermatitis and a possible rival to a drug from Novatis.